[Federal Register Volume 81, Number 42 (Thursday, March 3, 2016)]
[Notices]
[Pages 11173-11174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04715]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-75-2015]


Foreign-Trade Zone (FTZ) 76--Bridgeport, Connecticut; 
Authorization of Production Activity; MannKind Corporation, Subzone 76B 
(Inhalable Insulin), Danbury, Connecticut

    On October 29, 2015, MannKind Corporation submitted a notification 
of proposed production activity to the Foreign-Trade Zones (FTZ) Board 
for its facilities within Subzone 76B, in Danbury, Connecticut.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (80 FR 70751, November 16, 2015). The 
FTZ Board has determined that no further review of the activity is 
warranted at this time. The production activity described in the 
notification is authorized, subject to the

[[Page 11174]]

FTZ Act and the Board's regulations, including Section 400.14.

    Dated: February 26, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016-04715 Filed 3-2-16; 8:45 am]
 BILLING CODE 3510-DS-P